Ac immune to present at the jefferies london healthcare conference

Lausanne, switzerland, oct. 25, 2021 (globe newswire) -- ac immune sa (nasdaq: aciu), a clinical-stage biopharmaceutical company pioneering precision medicine for neurodegenerative diseases, today announced that company management will participate in a fireside chat and one-on-one investor meetings during the virtual portion of the jefferies london healthcare conference, taking place november 18-19, 2021.
ACIU Ratings Summary
ACIU Quant Ranking